Notice: This company has been marked as potentially delisted and may not be actively trading. Digirad (DRAD) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock DRAD vs. OM, POCI, NXL, PTHL, NRXS, IRIX, QTI, MOVE, STRR, and BSGMShould you be buying Digirad stock or one of its competitors? The main competitors of Digirad include Outset Medical (OM), Precision Optics (POCI), Nexalin Technology (NXL), Pheton Holdings Ltd Class A Ordinary Shares (PTHL), NeurAxis (NRXS), IRIDEX (IRIX), QT Imaging (QTI), Movano (MOVE), Star Equity (STRR), and BioSig Technologies (BSGM). Digirad vs. Outset Medical Precision Optics Nexalin Technology Pheton Holdings Ltd Class A Ordinary Shares NeurAxis IRIDEX QT Imaging Movano Star Equity BioSig Technologies Digirad (NASDAQ:DRAD) and Outset Medical (NASDAQ:OM) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, media sentiment, analyst recommendations, community ranking, institutional ownership and profitability. Is DRAD or OM more profitable? Digirad has a net margin of -5.32% compared to Outset Medical's net margin of -112.57%. Digirad's return on equity of -3.75% beat Outset Medical's return on equity.Company Net Margins Return on Equity Return on Assets Digirad-5.32% -3.75% -0.85% Outset Medical -112.57%-175.64%-38.61% Do analysts recommend DRAD or OM? Outset Medical has a consensus target price of $57.00, suggesting a potential upside of 388.64%. Given Outset Medical's stronger consensus rating and higher possible upside, analysts plainly believe Outset Medical is more favorable than Digirad.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Digirad 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Outset Medical 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Which has more volatility and risk, DRAD or OM? Digirad has a beta of 0.18, meaning that its stock price is 82% less volatile than the S&P 500. Comparatively, Outset Medical has a beta of 2.01, meaning that its stock price is 101% more volatile than the S&P 500. Does the media favor DRAD or OM? In the previous week, Outset Medical had 4 more articles in the media than Digirad. MarketBeat recorded 4 mentions for Outset Medical and 0 mentions for Digirad. Outset Medical's average media sentiment score of 1.02 beat Digirad's score of 0.00 indicating that Outset Medical is being referred to more favorably in the news media. Company Overall Sentiment Digirad Neutral Outset Medical Positive Does the MarketBeat Community favor DRAD or OM? Digirad received 294 more outperform votes than Outset Medical when rated by MarketBeat users. Likewise, 70.35% of users gave Digirad an outperform vote while only 38.10% of users gave Outset Medical an outperform vote. CompanyUnderperformOutperformDigiradOutperform Votes31870.35% Underperform Votes13429.65% Outset MedicalOutperform Votes2438.10% Underperform Votes3961.90% Do institutionals & insiders have more ownership in DRAD or OM? 11.4% of Digirad shares are owned by institutional investors. 12.5% of Digirad shares are owned by insiders. Comparatively, 4.1% of Outset Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has preferable valuation and earnings, DRAD or OM? Digirad has higher revenue and earnings than Outset Medical. Digirad is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDigirad$114.18M0.10-$4.63M-$0.35-6.94Outset Medical$113.69M0.37-$172.80M-$37.18-0.31 SummaryDigirad beats Outset Medical on 11 of the 18 factors compared between the two stocks. Remove Ads Get Digirad News Delivered to You Automatically Sign up to receive the latest news and ratings for DRAD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DRAD vs. The Competition Export to ExcelMetricDigiradElectromedical Equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.57M$3.31B$5.61B$7.72BDividend Yield83.65%1.63%5.33%4.03%P/E Ratio-0.7714.5723.5718.60Price / Sales0.1043.64369.1789.09Price / Cash0.6944.0938.1734.64Price / Book0.243.356.794.10Net Income-$4.63M$94.03M$3.20B$247.10M Digirad Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DRADDigiradN/A$2.43-7.7%N/A+173.8%$11.57M$114.18M-0.77618Gap DownOMOutset Medical1.9533 of 5 stars$10.49+4.4%$67.50+543.5%-62.2%$36.13M$113.69M-4.23520Positive NewsPOCIPrecision Optics0.3137 of 5 stars$4.41-6.7%N/A-25.6%$33.69M$18.68M-6.8980NXLNexalin Technology3.2413 of 5 stars$2.34-1.7%$5.00+113.7%+36.4%$31.13M$168,721.00-3.663Short Interest ↓Positive NewsGap UpPTHLPheton Holdings Ltd Class A Ordinary SharesN/A$3.91-7.8%N/AN/A$25.74M$572,291.000.0011News CoveragePositive NewsGap UpNRXSNeurAxisN/A$2.19-5.2%N/AN/A$16.58M$2.69M-1.1919Gap DownIRIXIRIDEX1.1625 of 5 stars$0.95-4.0%$2.00+110.5%-66.5%$15.80M$48.43M-1.42120Earnings ReportGap DownHigh Trading VolumeQTIQT ImagingN/A$0.55-8.3%N/A-50.5%$14.92M$4.00M0.00N/APositive NewsMOVEMovano2.4129 of 5 stars$2.06+0.5%$30.00+1,356.3%-68.1%$13.67M$902,000.00-0.4030Upcoming EarningsGap UpSTRRStar Equity1.1705 of 5 stars$2.67+10.3%N/A-43.2%$8.59M$50.38M-1.04460Positive NewsGap UpHigh Trading VolumeBSGMBioSig Technologies1.8031 of 5 stars$0.49-9.4%$2.75+456.9%-10.7%$8.51M$39,000.000.0050Gap DownHigh Trading Volume Remove Ads Related Companies and Tools Related Companies Outset Medical Competitors Precision Optics Competitors Nexalin Technology Competitors Pheton Holdings Ltd Class A Ordinary Shares Competitors NeurAxis Competitors IRIDEX Competitors QT Imaging Competitors Movano Competitors Star Equity Competitors BioSig Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DRAD) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Digirad Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Digirad With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DRAD Stock Free DRAD Stock Alerts